A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
He dismissed this outright. “No, it’s definitely the vaccines,” he insisted, before pivoting to his next pitch: Super Mineral ...
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...
The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...